Create your Personal Health Record and unlock support built around you
- Treatments and trials you qualify for
- Education for your stage of care
- Financial support for your medications
- Solutions to your side effects
Choosing Between CAR-T and Bispecific Antibodies: Patient Perspectives | Valeria Escobedo | #IMS2025
HealthTreeDescription
Deciding between CAR-T therapy and bispecific antibodies can be overwhelming for patients with multiple myeloma. In this insightful session, Valeria Escobedo shares how patients weigh the benefits, risks, and lifestyle considerations when choosing their treatment.
Watch the full course and our most up-to-date content here: https://linktr.ee/HealthTreeUniversity
Create a free account to track your progress, bookmark lessons, and keep up-to-date on the latest advancements in treating cancer!
Patients have the key to find cures for cancer. Learn more about HealthTree Cure Hub here: https://healthtree.org/curehub?utm_source=social+media&utm_medium=htu+youtube&utm_campaign=htu-curehub&utm_content=general
Educated and empowered patients have better outcomes. We've partnered with hundreds of medical experts and doctors to help you learn more about your disease.
#MultipleMyeloma #CAR-T #BispecificAntibodies #PatientPerspective #MyelomaTreatment #IMS2025 #CancerTreatmentChoices